Pfizer Ventures
Overview
Pfizer Ventures, the venture capital arm of Pfizer Inc., was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer . Pfizer Ventures seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer's pipeline and shape the future of the biopharmaceutical industry . The firm invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances . They identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer's pipeline and shape the future of the industry .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CellCentric | Jul 2024 | Series B | Co-investor |
| Normunity | Jan 2025 | Series B | Co-investor |
| ReCode Therapeutics | Sep 2023 | Series B Extension | Co-investor |
| TRIANA Biomedicines | Dec 2025 | Series B | Co-investor |
| Anaveon | Dec 2021 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pfizer Ventures based?
Pfizer Ventures is headquartered in New York City, New York, United States.
When was Pfizer Ventures founded?
Pfizer Ventures was founded in 2004.
How many portfolio companies does Pfizer Ventures have?
Pfizer Ventures has 44 portfolio companies in Caplight's dataset.
What are some companies in Pfizer Ventures's portfolio?
Portfolio companies visible on Caplight include CellCentric, Normunity, ReCode Therapeutics, TRIANA Biomedicines, Anaveon.
What was Pfizer Ventures's most recent investment shown here?
Pfizer Ventures's most recent investment in this portfolio sample was in TRIANA Biomedicines in 2025.
What sectors does Pfizer Ventures focus on?
Pfizer Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does Pfizer Ventures focus on?
Pfizer Ventures typically invests at the Mid stage.
What is Pfizer Ventures's AUM?
Pfizer Ventures's assets under management are estimated between $1.0B and $10.0B.